世界のオピオイド誘発性副作用治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Opioid Induced Side Effects Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5911
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、オピオイド誘発性副作用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リスペリドン、メチルフェニデート、セチリジン、その他）、用途別市場規模（薬物過剰摂取治療、疼痛治療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・オピオイド誘発性副作用治療の市場動向
・企業の競争状況、市場シェア
・オピオイド誘発性副作用治療の種類別市場規模と予測2016-2027（リスペリドン、メチルフェニデート、セチリジン、その他）
・オピオイド誘発性副作用治療の用途別市場規模と予測2016-2027（薬物過剰摂取治療、疼痛治療、その他）
・オピオイド誘発性副作用治療の北米市場規模2016-2027（アメリカ、カナダ）
・オピオイド誘発性副作用治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・オピオイド誘発性副作用治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・オピオイド誘発性副作用治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・オピオイド誘発性副作用治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Shionogi、Cubist Pharmaceuticals、SLA Pharma、AstraZeneca、AIKO Biotechnology、Progenics Pharmaceuticals）
・結論

Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.

Market Analysis and Insights: Global Opioid Induced Side Effects Treatment Market
The global Opioid Induced Side Effects Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Induced Side Effects Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Induced Side Effects Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Induced Side Effects Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Induced Side Effects Treatment market.

Global Opioid Induced Side Effects Treatment Scope and Market Size
Opioid Induced Side Effects Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Side Effects Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Risperidone
Methylphenidate
Cetirizine
Other

Segment by Application
Drug Overdose Treatment
Pain Treatment
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Shionogi
Cubist Pharmaceuticals
SLA Pharma
AstraZeneca
AIKO Biotechnology
Progenics Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Risperidone
1.2.3 Methylphenidate
1.2.4 Cetirizine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Opioid Induced Side Effects Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Overdose Treatment
1.3.3 Pain Treatment
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Opioid Induced Side Effects Treatment Market Perspective (2016-2027)
2.2 Opioid Induced Side Effects Treatment Growth Trends by Regions
2.2.1 Opioid Induced Side Effects Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opioid Induced Side Effects Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Opioid Induced Side Effects Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Opioid Induced Side Effects Treatment Industry Dynamic
2.3.1 Opioid Induced Side Effects Treatment Market Trends
2.3.2 Opioid Induced Side Effects Treatment Market Drivers
2.3.3 Opioid Induced Side Effects Treatment Market Challenges
2.3.4 Opioid Induced Side Effects Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Side Effects Treatment Players by Revenue
3.1.1 Global Top Opioid Induced Side Effects Treatment Players by Revenue (2016-2021)
3.1.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Opioid Induced Side Effects Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opioid Induced Side Effects Treatment Revenue
3.4 Global Opioid Induced Side Effects Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Side Effects Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Side Effects Treatment Revenue in 2020
3.5 Opioid Induced Side Effects Treatment Key Players Head office and Area Served
3.6 Key Players Opioid Induced Side Effects Treatment Product Solution and Service
3.7 Date of Enter into Opioid Induced Side Effects Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Induced Side Effects Treatment Breakdown Data by Type
4.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Type (2016-2021)
4.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2022-2027)

5 Opioid Induced Side Effects Treatment Breakdown Data by Application
5.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Application (2016-2021)
5.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Opioid Induced Side Effects Treatment Market Size (2016-2027)
6.2 North America Opioid Induced Side Effects Treatment Market Size by Type
6.2.1 North America Opioid Induced Side Effects Treatment Market Size by Type (2016-2021)
6.2.2 North America Opioid Induced Side Effects Treatment Market Size by Type (2022-2027)
6.2.3 North America Opioid Induced Side Effects Treatment Market Size by Type (2016-2027)
6.3 North America Opioid Induced Side Effects Treatment Market Size by Application
6.3.1 North America Opioid Induced Side Effects Treatment Market Size by Application (2016-2021)
6.3.2 North America Opioid Induced Side Effects Treatment Market Size by Application (2022-2027)
6.3.3 North America Opioid Induced Side Effects Treatment Market Size by Application (2016-2027)
6.4 North America Opioid Induced Side Effects Treatment Market Size by Country
6.4.1 North America Opioid Induced Side Effects Treatment Market Size by Country (2016-2021)
6.4.2 North America Opioid Induced Side Effects Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Opioid Induced Side Effects Treatment Market Size (2016-2027)
7.2 Europe Opioid Induced Side Effects Treatment Market Size by Type
7.2.1 Europe Opioid Induced Side Effects Treatment Market Size by Type (2016-2021)
7.2.2 Europe Opioid Induced Side Effects Treatment Market Size by Type (2022-2027)
7.2.3 Europe Opioid Induced Side Effects Treatment Market Size by Type (2016-2027)
7.3 Europe Opioid Induced Side Effects Treatment Market Size by Application
7.3.1 Europe Opioid Induced Side Effects Treatment Market Size by Application (2016-2021)
7.3.2 Europe Opioid Induced Side Effects Treatment Market Size by Application (2022-2027)
7.3.3 Europe Opioid Induced Side Effects Treatment Market Size by Application (2016-2027)
7.4 Europe Opioid Induced Side Effects Treatment Market Size by Country
7.4.1 Europe Opioid Induced Side Effects Treatment Market Size by Country (2016-2021)
7.4.2 Europe Opioid Induced Side Effects Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size (2016-2027)
8.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type
8.2.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application
8.3.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region
8.4.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Opioid Induced Side Effects Treatment Market Size (2016-2027)
9.2 Latin America Opioid Induced Side Effects Treatment Market Size by Type
9.2.1 Latin America Opioid Induced Side Effects Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Opioid Induced Side Effects Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Opioid Induced Side Effects Treatment Market Size by Type (2016-2027)
9.3 Latin America Opioid Induced Side Effects Treatment Market Size by Application
9.3.1 Latin America Opioid Induced Side Effects Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Opioid Induced Side Effects Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Opioid Induced Side Effects Treatment Market Size by Application (2016-2027)
9.4 Latin America Opioid Induced Side Effects Treatment Market Size by Country
9.4.1 Latin America Opioid Induced Side Effects Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Opioid Induced Side Effects Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size (2016-2027)
10.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type
10.2.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application
10.3.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country
10.4.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Shionogi
11.1.1 Shionogi Company Details
11.1.2 Shionogi Business Overview
11.1.3 Shionogi Opioid Induced Side Effects Treatment Introduction
11.1.4 Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2016-2021)
11.1.5 Shionogi Recent Development
11.2 Cubist Pharmaceuticals
11.2.1 Cubist Pharmaceuticals Company Details
11.2.2 Cubist Pharmaceuticals Business Overview
11.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.2.4 Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2016-2021)
11.2.5 Cubist Pharmaceuticals Recent Development
11.3 SLA Pharma
11.3.1 SLA Pharma Company Details
11.3.2 SLA Pharma Business Overview
11.3.3 SLA Pharma Opioid Induced Side Effects Treatment Introduction
11.3.4 SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2016-2021)
11.3.5 SLA Pharma Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Opioid Induced Side Effects Treatment Introduction
11.4.4 AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Details
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2016-2021)
11.5.5 AIKO Biotechnology Recent Development
11.6 Progenics Pharmaceuticals
11.6.1 Progenics Pharmaceuticals Company Details
11.6.2 Progenics Pharmaceuticals Business Overview
11.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.6.4 Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2016-2021)
11.6.5 Progenics Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Risperidone
Table 3. Key Players of Methylphenidate
Table 4. Key Players of Cetirizine
Table 5. Key Players of Other
Table 6. Global Opioid Induced Side Effects Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Opioid Induced Side Effects Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Opioid Induced Side Effects Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Opioid Induced Side Effects Treatment Market Share by Regions (2016-2021)
Table 10. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Opioid Induced Side Effects Treatment Market Share by Regions (2022-2027)
Table 12. Opioid Induced Side Effects Treatment Market Trends
Table 13. Opioid Induced Side Effects Treatment Market Drivers
Table 14. Opioid Induced Side Effects Treatment Market Challenges
Table 15. Opioid Induced Side Effects Treatment Market Restraints
Table 16. Global Opioid Induced Side Effects Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Opioid Induced Side Effects Treatment Market Share by Players (2016-2021)
Table 18. Global Top Opioid Induced Side Effects Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Side Effects Treatment as of 2020)
Table 19. Ranking of Global Top Opioid Induced Side Effects Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Opioid Induced Side Effects Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Opioid Induced Side Effects Treatment Product Solution and Service
Table 23. Date of Enter into Opioid Induced Side Effects Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Opioid Induced Side Effects Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Opioid Induced Side Effects Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Opioid Induced Side Effects Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Opioid Induced Side Effects Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Opioid Induced Side Effects Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Opioid Induced Side Effects Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Opioid Induced Side Effects Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Opioid Induced Side Effects Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Opioid Induced Side Effects Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Opioid Induced Side Effects Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Opioid Induced Side Effects Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Opioid Induced Side Effects Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Opioid Induced Side Effects Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Opioid Induced Side Effects Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Opioid Induced Side Effects Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Opioid Induced Side Effects Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Opioid Induced Side Effects Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Opioid Induced Side Effects Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Opioid Induced Side Effects Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Opioid Induced Side Effects Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Opioid Induced Side Effects Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Opioid Induced Side Effects Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Shionogi Company Details
Table 64. Shionogi Business Overview
Table 65. Shionogi Opioid Induced Side Effects Treatment Product
Table 66. Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2016-2021) & (US$ Million)
Table 67. Shionogi Recent Development
Table 68. Cubist Pharmaceuticals Company Details
Table 69. Cubist Pharmaceuticals Business Overview
Table 70. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product
Table 71. Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2016-2021) & (US$ Million)
Table 72. Cubist Pharmaceuticals Recent Development
Table 73. SLA Pharma Company Details
Table 74. SLA Pharma Business Overview
Table 75. SLA Pharma Opioid Induced Side Effects Treatment Product
Table 76. SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2016-2021) & (US$ Million)
Table 77. SLA Pharma Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Opioid Induced Side Effects Treatment Product
Table 81. AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. AIKO Biotechnology Company Details
Table 84. AIKO Biotechnology Business Overview
Table 85. AIKO Biotechnology Opioid Induced Side Effects Treatment Product
Table 86. AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2016-2021) & (US$ Million)
Table 87. AIKO Biotechnology Recent Development
Table 88. Progenics Pharmaceuticals Company Details
Table 89. Progenics Pharmaceuticals Business Overview
Table 90. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product
Table 91. Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2016-2021) & (US$ Million)
Table 92. Progenics Pharmaceuticals Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Induced Side Effects Treatment Market Share by Type: 2020 VS 2027
Figure 2. Risperidone Features
Figure 3. Methylphenidate Features
Figure 4. Cetirizine Features
Figure 5. Other Features
Figure 6. Global Opioid Induced Side Effects Treatment Market Share by Application: 2020 VS 2027
Figure 7. Drug Overdose Treatment Case Studies
Figure 8. Pain Treatment Case Studies
Figure 9. Other Case Studies
Figure 10. Opioid Induced Side Effects Treatment Report Years Considered
Figure 11. Global Opioid Induced Side Effects Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Opioid Induced Side Effects Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Opioid Induced Side Effects Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Opioid Induced Side Effects Treatment Market Share by Regions (2022-2027)
Figure 15. Global Opioid Induced Side Effects Treatment Market Share by Players in 2020
Figure 16. Global Top Opioid Induced Side Effects Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Side Effects Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Opioid Induced Side Effects Treatment Revenue in 2020
Figure 18. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Opioid Induced Side Effects Treatment Market Share by Type (2016-2027)
Figure 22. North America Opioid Induced Side Effects Treatment Market Share by Application (2016-2027)
Figure 23. North America Opioid Induced Side Effects Treatment Market Share by Country (2016-2027)
Figure 24. United States Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Opioid Induced Side Effects Treatment Market Share by Type (2016-2027)
Figure 28. Europe Opioid Induced Side Effects Treatment Market Share by Application (2016-2027)
Figure 29. Europe Opioid Induced Side Effects Treatment Market Share by Country (2016-2027)
Figure 30. Germany Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Opioid Induced Side Effects Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Opioid Induced Side Effects Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Opioid Induced Side Effects Treatment Market Share by Region (2016-2027)
Figure 40. China Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Opioid Induced Side Effects Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Opioid Induced Side Effects Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Opioid Induced Side Effects Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Opioid Induced Side Effects Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Shionogi Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2016-2021)
Figure 60. Cubist Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2016-2021)
Figure 61. SLA Pharma Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2016-2021)
Figure 63. AIKO Biotechnology Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2016-2021)
Figure 64. Progenics Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のオピオイド離脱治療市場規模・現状・予測（2021年-2027年）

Global Opioid Withdrawal Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4618 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、オピオイド離脱治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、吐き気止め薬、鎮痛薬、その他）、用途別市場規模（病院薬局、小売薬局、オンラインストア）、主要地域別市場規模（北米、アメリカ、...

世界の非オピオイド疼痛治療市場規模・現状・予測（2021年-2027年）

Global Non-Opioid Pain Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5894 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、非オピオイド疼痛治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療大麻治療、カプサイシン由来治療、メントール含有治療、オメガ3脂肪酸含有治療、ボツリヌス毒素）、用途別市場規模（整形外科・筋骨格痛...

世界の薬物誘発性聴器毒性治療市場規模・現状・予測（2021年-2027年）

Global Drug Induced Ototoxicity Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4158 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、薬物誘発性聴器毒性治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（代替療法、医薬品、補聴器、人工内耳、福祉機器（ALD））、用途別市場規模（蝸牛薬原因聴器毒性、前庭薬原因聴器毒性）、主要地域別市場...

世界のヘパリン起因性血小板減少症 (HIT) 治療市場規模・現状・予測（2021年-2027年）

Global Heparin-Induced Thrombocytopenia (HIT) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4300 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ヘパリン起因性血小板減少症 (HIT) 治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断、治療）、用途別市場規模（病院、診断センター、専門医クリニック、病院薬局）、主要地域別市場規模（北米、ア...

世界のオピオイド使用障害市場規模・現状・予測（2021年-2027年）

Global Opioid Use Disorder Market Size, Status and Forecast 2021-2027
QFJ1-4617 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、オピオイド使用障害の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、メタドン、ナルトレキソン）、用途別市場規模（中等度疼痛治療、重度疼痛治療）、主要地域別市場規模（北米、アメリカ、欧州...

世界の化学療法による悪心＆嘔吐治療市場規模・現状・予測（2021年-2027年）

Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5654 2021年6月 115Pages
QYResearch社発行の本調査レポートでは、化学療法による悪心＆嘔吐治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アロキシ（パロノセトロン）、キトリル（グラニセトロン）、エメンド（アプレピタント）、その他）、用途別市場規模（急性悪心＆嘔吐...

世界のオピオイド薬市場規模・現状・予測（2021年-2027年）

Global Opioid Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5910 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、オピオイド薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブプレノルフィン、フェンタニル、ヒドロコドン、モルヒネ、オキシコドン、トラマドール、その他）、用途別市場規模（麻酔、鎮痛、咳抑制、下痢抑制、...

世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3999 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、化学療法誘発性血小板減少症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の末梢神経炎治療市場規模・現状・予測（2021年-2027年）

Global Peripheral Neuritis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5939 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、末梢神経炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（糖尿病性末梢神経障害（DPN）、化学療法誘発性末梢神経障害（CIPN）、特発性末梢神経障害（IPN）、その他）、用途別市場規模（病院薬局、...

化学療法誘発性末梢神経障害治療のグローバル市場2021

Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Market Report 2021
QAF27614 2021年3月23日 144Pages
本市場調査資料では、世界の化学療法誘発性末梢神経障害治療市場について種類別（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）、用途別（プラチナ剤、タキサン、ビンカアルカロイド、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。...

世界の非オピオイド疼痛治療市場規模・現状・予測（2021年-2027年） Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals. With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for …
世界の薬物誘発性聴器毒性治療市場規模・現状・予測（2021年-2027年） Drug induced ototoxicity is defined as damage to the Cochlea and vestibule caused by the use or exposure to certain therapeutic or chemical drugs Common OTOTOXIC drugs are: aminoglycoside antibiotics, salicylic acid, quinine and loop diuretics, anti-tumor chemotherapy drugs. Market Analysis and Insi…
世界のオピオイド離脱治療市場規模・現状・予測（2021年-2027年） In some cases, usage of opioids causes addiction, and opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment…
世界のヘパリン起因性血小板減少症 (HIT) 治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heparin-Induced Thrombocytopenia (HIT) Treatment Market The global Heparin-Induced Thrombocytopenia (HIT) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard ac…
世界の化学療法による悪心＆嘔吐治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Chemotheraphy-induced Nausea and Vomitting Treatment Market The global Chemotheraphy-induced Nausea and Vomitting Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-sta…